無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

A型ボツリヌス毒素製剤の中国市場分析・予測

Investigation Report on China's Botulinum Toxin Type A Market, 2018-2022

発行 China Research and Intelligence 商品コード 762940
出版日 ページ情報 英文 30 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.39円で換算しております。
Back to Top
A型ボツリヌス毒素製剤の中国市場分析・予測 Investigation Report on China's Botulinum Toxin Type A Market, 2018-2022
出版日: 2019年01月02日 ページ情報: 英文 30 Pages
概要

当レポートでは、中国のA型ボツリヌス毒素製剤市場について調査分析し、状況、市場規模、主要メーカー、市場競合、小売価格、市場の見通しについて、体系的な情報を提供しています。

第1章 A型ボツリヌス毒素製剤の関連概念

  • A型ボツリヌス毒素製剤の適応
  • 中国におけるA型ボツリヌス毒素製剤開発の歴史
  • 中国におけるA型ボツリヌス毒素製剤の政府承認

第2章 中国におけるA型ボツリヌス毒素製剤の売上

  • 売上額
    • 総売上額
    • 売上額:地域別
  • 売上高
    • 総売上高
    • 売上高:地域別
  • 売上:剤形別

第3章 中国におけるA型ボツリヌス毒素製剤主要メーカーの分析

  • 主要メーカーの市場シェア分析
  • Allergan
    • 企業プロファイル
    • 中国における売上
  • Lanzhou Institute of Biological Products Co., Ltd.
    • 企業プロファイル
    • 中国における売上
  • 中国で違法に販売されるA型ボツリヌス毒素製剤の分析

第4章 中国におけるA型ボツリヌス毒素製剤の価格

  • Allergan (Botox)
  • Lanzhou Institute of Biological Products Co., Ltd. (Hengli)

第5章 中国におけるA型ボツリヌス毒素製剤市場の見通し

  • 市場発展に影響を与える要因の分析
  • 市場規模の予測
  • 市場動向の予測
目次
Product Code: 1901368

As the most toxic one of the eight antigenic types of botulinum, Botulinum Toxin Type A can irreversibly unite with presynaptic membrane within one hour. The targeted striated muscle will be relaxed usually 48 to 72 hours after the injection of Botulinum Toxin Type A. And the effect is maximally visible seven to 14 days following injection. Such muscle relaxation usually lasts for three to six months but varies greatly among different people. For some people, it can last up to 18 months.

On Apr. 15, 2002, Botulinum Toxin Type A was approved by the FDA as a medical cosmetic that is injected to temporarily improve the appearance of moderate to severe glabellar lines. Later, some generic drugs appeared on the market. In addition to the imported Botulinum Toxin Type A (trade name: Botox) produced by Allergan, the Botulinum Toxin Type A products in China also include Botulinum Toxin Type A (trade name: Hengli) developed by Lanzhou Institute of Biological Products Co., Ltd.

In China, the medical use of Botulinum Toxin Type A is to treat adult blepharospasm and prosopospasm and some strabismuses, especially acute paralytic strabismus, concomitant strabismus, strabismus caused by endocrine diseases, and the strabismus that cannot be corrected surgically for those aged 12 and above. The incidence of facial neuropathy is increasing in China. Many people are attacked by prosopospasm when they are over-stressed or fatigued. Seeing global annual incidence of about 0.003%, facial neuropathy is more common in women than in men, and more common in middle-aged and elderly people than in people from other age groups.

However, more users of Botulinum Toxin Type A are women who pursue a thin face or less wrinkles. With more than 10 million cosmetic surgeries every year, the market size of medical beauty in China has exceeded USD 10 billion and is still growing. As the demand for Botulinum Toxin Type A is expanding, some medical institutions and beauty salons have begun to inject Botulinum Toxin Type A smuggled from South Korea, France, Germany, etc. for their customers. Although the Chinese government only approved the sale of Botox and Hengli, smuggled Botulinum Toxin Type A products are easily available in China.

It is expected that, with the development of China's economy, the rise of income, and the change of consumption habit, Chinese people will spend more in medical beauty, and the market size of Botulinum Toxin Type A will continue to grow in China in the next few years.

Topics Covered:

  • Status of China's medical beauty market
  • Sales of Botulinum Toxin Type A in China
  • Competition on China's Botulinum Toxin Type A market
  • Major factors influencing the development of China's Botulinum Toxin Type A market
  • Prospect of China's Botulinum Toxin Type A market from 2018 to 2022

Table of Contents

1 Relevant Concepts of Botulinum Toxin Type A

  • 1.1 Indications for Botulinum Toxin Type A
  • 1.2 Development of Botulinum Toxin Type A in China
  • 1.3 Governmental Approval of Botulinum Toxin Type A in China

2 Sales of Botulinum Toxin Type A in China, 2013-2017

  • 2.1 Sales Value of Botulinum Toxin Type A in China
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Region
  • 2.2 Sales Volume of Botulinum Toxin Type A in China
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Region
  • 2.3 Sales of Botulinum Toxin Type A by Dosage Form in China, 2013-2017

3 Analysis on Major Manufacturers of Botulinum Toxin Type A in China, 2013-2017

  • 3.1 Analysis on Market Share of Major Manufacturers of Botulinum Toxin Type A
    • 3.1.1 Market Share by Sales Value
    • 3.1.2 Market Share by Sales Volume
  • 3.2 Allergan
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of Allergan's Botulinum Toxin Type A in China
  • 3.3 Lanzhou Institute of Biological Products Co., Ltd.
    • 3.3.1 Enterprise Profile
    • 3.3.2 Sales of Lanzhou Institute of Biological Products Co., Ltd.'s Botulinum Toxin Type A in China
  • 3.4 Analysis on Botulinum Toxin Type A Illegally Sold in China

4 Prices of Botulinum Toxin Type A in China, 2017-2018

  • 4.1 Allergan (Botox)
  • 4.2 Lanzhou Institute of Biological Products Co., Ltd. (Hengli)

5 Prospect of China's Botulinum Toxin Type A Market, 2018-2022

  • 5.1 Major Factors Influencing Development of China's Botulinum Toxin Type A Market
  • 5.2 Forecast on Market Size
  • 5.3 Forecast on Market Trend

Selected Charts

  • Chart Governmental Approval of Botulinum Toxin Type A in China
  • Chart Sales of Botulinum Toxin Type A in China, 2013-2017
  • Chart Sales Value of Botulinum Toxin Type A in Parts of China, 2013-2017
  • Chart Sales Volume of Botulinum Toxin Type A in China, 2013-2017
  • Chart Sales Volume of Botulinum Toxin Type A in Parts of China, 2013-2017
  • Chart Sales Value of Botulinum Toxin Type A Injections in China, 2013-2017
  • Chart Sales Volume of Botulinum Toxin Type A Injections in China, 2013-2017
  • Chart Market Share of Top 5 Manufacturers of Botulinum Toxin Type A by Sales Value in China, 2013-2017
  • Chart Market Share of Top 5 Manufacturers of Botulinum Toxin Type A by Sales Volume in China, 2013-2017
  • Chart Sales Value of Allergan's Botulinum Toxin Type A, 2013-2017
  • Chart Sales Volume of Allergan's Botulinum Toxin Type A, 2013-2017
  • Chart Sales Value of Lanzhou Institute of Biological Products Co., Ltd.'s Botulinum Toxin Type A, 2013-2017
  • Chart Sales Volume of Lanzhou Institute of Biological Products Co., Ltd.'s Botulinum Toxin Type A, 2013-2017
  • Chart Prices of Allergan's Botulinum Toxin Type A (Botox) in Parts of China, 2017-2018
  • Chart Prices of Lanzhou Institute of Biological Products Co., Ltd.'s Botulinum Toxin Type A (Hengli) in Parts of China, 2017-2018
  • Chart Forecast on Sales Value of Botulinum Toxin Type A in China, 2018-2022
Back to Top